293 related articles for article (PubMed ID: 10377188)
41. Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells.
Wang Y; Curry HM; Zwilling BS; Lafuse WP
J Immunol; 2005 May; 174(9):5687-94. PubMed ID: 15843570
[TBL] [Abstract][Full Text] [Related]
42. Failure of MHC class II expression in neonatal alveolar macrophages: potential role of class II transactivator.
Lee PT; Holt PG; McWilliam AS
Eur J Immunol; 2001 Aug; 31(8):2347-56. PubMed ID: 11477547
[TBL] [Abstract][Full Text] [Related]
43. 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter.
Adamski J; Ma Z; Nozell S; Benveniste EN
Mol Endocrinol; 2004 Aug; 18(8):1963-74. PubMed ID: 15143155
[TBL] [Abstract][Full Text] [Related]
44. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate.
Lian RH; Kotwal GJ; Wellhausen SR; Hunt LA; Justus DE
J Immunol; 1996 Jul; 157(2):864-73. PubMed ID: 8752940
[TBL] [Abstract][Full Text] [Related]
45. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.
Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U
Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
[TBL] [Abstract][Full Text] [Related]
47. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes.
Lu Y; Tschickardt ME; Schmidt BJ; Blanck G
Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472
[TBL] [Abstract][Full Text] [Related]
48. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
[TBL] [Abstract][Full Text] [Related]
49. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
[TBL] [Abstract][Full Text] [Related]
50. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
Han Y; Zhou ZH; Ransohoff RM
J Immunol; 1999 Aug; 163(3):1435-40. PubMed ID: 10415044
[TBL] [Abstract][Full Text] [Related]
51. Selective modulation of MHC class II chaperons by a novel IFN-γ-inducible class II transactivator variant in lung adenocarcinoma A549 cells.
Chiu BL; Li CH; Chang CC
Biochem Biophys Res Commun; 2013 Oct; 440(1):190-5. PubMed ID: 24055710
[TBL] [Abstract][Full Text] [Related]
52. Down-regulation of interferon-gamma signaling by gene transfer of Stat1 mutant in mesangial cells.
Sakatsume M; Narita I; Yamazaki H; Saito A; Nakagawa Y; Kuriyama H; Kuwano R; Gejyo F; Arakawa M
Kidney Int; 2000 Feb; 57(2):455-63. PubMed ID: 10652022
[TBL] [Abstract][Full Text] [Related]
53. Adenosine signaling inhibits CIITA-mediated MHC class II transactivation in lung fibroblast cells.
Fang M; Xia J; Wu X; Kong H; Wang H; Xie W; Xu Y
Eur J Immunol; 2013 Aug; 43(8):2162-73. PubMed ID: 23681904
[TBL] [Abstract][Full Text] [Related]
54. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
55. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression.
Schmidt K; Wies E; Neipel F
J Virol; 2011 May; 85(9):4530-7. PubMed ID: 21345951
[TBL] [Abstract][Full Text] [Related]
56. Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gamma-induced major histocompatibility complex class II gene expression.
Lang C; Algner M; Beinert N; Gross U; Lüder CG
Microbes Infect; 2006 Jul; 8(8):1994-2005. PubMed ID: 16824778
[TBL] [Abstract][Full Text] [Related]
57. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
[TBL] [Abstract][Full Text] [Related]
58. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.
Morimoto Y; Toyota M; Satoh A; Murai M; Mita H; Suzuki H; Takamura Y; Ikeda H; Ishida T; Sato N; Tokino T; Imai K
Br J Cancer; 2004 Feb; 90(4):844-52. PubMed ID: 14970863
[TBL] [Abstract][Full Text] [Related]
59. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
Kong X; Fang M; Li P; Fang F; Xu Y
J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
[TBL] [Abstract][Full Text] [Related]
60. Influenza A virus abrogates IFN-gamma response in respiratory epithelial cells by disruption of the Jak/Stat pathway.
Uetani K; Hiroi M; Meguro T; Ogawa H; Kamisako T; Ohmori Y; Erzurum SC
Eur J Immunol; 2008 Jun; 38(6):1559-73. PubMed ID: 18493979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
